Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Memorial Sloan Kettering Nassau, New York

Local Institution - 0010, Mineola

Local Institution - 0006, Pittsburgh

Johns Hopkins Cancer Center, Baltimore

Novant Health Oncology Specialists, Winston-Salem

Duke University, Durham

Charleston Hematology Oncology Associates, Pa, Charleston

Winship Cancer Institute., Atlanta

Summit Cancer Care, Savannah

Cleveland Clinic Florida, Weston

Tennessee Oncology, PLLC - SCRI - PPDS, Nashville

University Of Louisville Medical Center, Inc., Dba, Louisville

The Ohio State University, Columbus

Henry Ford Health System, Detroit

Cancer Center Of Kansas, Wichita

Local Institution - 0015, Lincoln

Local Institution - 0036, Albuquerque

Lovelace Cancer Care, Albuquerque

New Mexico Cancer Care Alliance, Albuquerque

New Mexico Cancer Care Center, Albuquerque

The Cancer Center at Presbyterian, Albuquerque

Sharp Memorial Hospital, San Diego

Cancer Center Of Central Connecticut, Plainville

Local Institution - 0029, Boston

Local Institution - 0030, Boston

Massachusetts General Hospital, Boston

Hackensack University Medical Center, Hackensack

Fox Chase Cancer Center, Philadelphia

Vanderbilt University Medical Center, Nashville

Local Institution - 0022, Kingston

Local Institution - 0023, Sault Ste. Marie

Csss De St-Jerome, Saint-Jérôme